Capital Markets Day and investor conferences
Oxford Biomedica PLC has announced its Capital Markets Day will be held on June 2, 2026, at the London Stock Exchange Group headquarters. The company will also participate in several upcoming investor conferences, including the UBS European Healthcare Conference on March 3-4, 2026, the Berenberg UK Corporate Conference on March 17-19, 2026, the Needham Virtual Healthcare Conference on April 13-16, 2026, and the Berenberg Midsummer Midcaps Conference on June 4-5, 2026. Additionally, Oxford Biomedica will report its preliminary results for the twelve months ended December 31, 2025, on March 26, 2026, followed by a virtual analyst briefing.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 3 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces the date of its Capital Markets Day and participation at upcoming investor conferences.
Capital Markets Day
OXB will hold its Capital Markets Day at the London Stock Exchange Group (LSEG) headquarters on 2 June 2026. Further details, including the agenda and registration information, will be provided in due course.
Upcoming Investor Conferences
UBS European Healthcare Conference
Date: 3 - 4 March 2026
Location: London, UK
Berenberg UK Corporate Conference
Date: 17- 19 March 2026
Location: Watford, UK
25th Annual Needham Virtual Healthcare Conference
Date: 13 - 16 April 2026
Location: Virtual
Berenberg Midsummer Midcaps Conference
Date: 4 - 5 June 2026
Location: Ascot, UK
Investors attending any of the above conferences who would like to meet with OXB are welcome to contact the Company's IR team via ir@oxb.com.
Live webcasts and recordings of presentations, where available, will be accessible under 'Results, Reports, Presentations & Webcasts' in the Investor Relations section of OXB's website at www.oxb.com.
FY 2025 Preliminary Results
As previously announced, OXB will report its preliminary results for the twelve months ended 31 December 2025 on 26 March 2026. OXB's management team, led by Dr. Frank Mathias, Chief Executive Officer, Dr. Lucy Crabtree, Chief Financial Officer, and Dr. Sébastien Ribault, Chief Business Officer, will host a virtual analyst briefing at 13:00 GMT / 08:00 ET. To register, please contact oxb@icrhealthcare.com.
For details of other upcoming financial events, please refer to the Company's investor calendar at https://oxb.com/investor-events/.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.